Overall, the results from our in vitro and in vivo studies support the anti-proliferative, pro-apoptotic, anti-angiogenic and anti-tumorigenic properties of delphinidin in human NSCLC cells that overexpress EGFR/VEGFR2. Here, EGFR is linked to non-small cell lung carcinoma.